bpc-157 intramuscular or subcutaneous can you inject bpc 157 in the muscle Dosing (Common Protocols) πΉ Oral / β’ 500 mcg daily β’ Duration: 6 weeks πΉ / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved bpc-157 injection subcutaneous vs intramuscular
Description
Patients aged 18 or older with AIS within 14 days, NIHSS score 6, and a pre-stroke mRS of 0 or 1 were included
Although both involve the injection of HA into the skin, Biorevitalization places cross-linked HA, superficially under the skin to stimulate skin rejuvenation
Yes, switching forms is a valid strategy when symptoms remain despite normal labs
In 2022, the FDA officially approved the combination of methotrexate with pegloticase when pegloticase treatment is given
Low dose naltrexone (again-alone!) resulted in significant clinical improvement in 75% of these patients, with complete remission noted in 25%
